Emergent Biosolutions Inc
The printable version is no longer supported and may have rendering errors. Please update your browser bookmarks and please use the default browser print function instead.
Background
Emergent BioSolutions (NYSE: EBS) is a multinational specialty biopharmaceutical company headquartered in Rockville, Maryland. It develops vaccines and therapeutics for infectious diseases, oncology and autoimmune disorders.
People
- Michael Milligan - Secretary General
- Thomas Barmüller - Director EMEA
- Aderbal Bonturi Pereira - Latin America Director
- Sabine Lobnig - Communications & Regulatory Officer
Affiliations
- Emergent Biosolutions Inc was a donor to the Science Media Centre in 2010 and 2011 according to the SMC.[1]
Contact
- Corporate
- 2273 Research Boulevard
- Suite 400
- Rockville, MD 20850
- USA
- Tel: 301-795-1800
- Fax: 301-795-1899
Notes
- ↑ Data from Internet Archive holdings of the Science Media Centre website, 2002-2013. May 2010 http://web.archive.org/web/20100822091312/http://www.sciencemediacentre.org/pages/about/funding.htm Jun 2011 http://web.archive.org/web/20110807075127/http://www.sciencemediacentre.org/pages/about/funding.htm